Blueprint MedTech Cycle 2 Annoucement - POCTRN
The Point of Care Technology Research Network develops technologies with clinical applications using a network model that enhances complementary strengths and builds multidisciplinary partnerships.

POCTRN and COVID-19
Explore RADx
RADx Tech
RADx Tech II
RADx Tech High-Performance Tests
RADx Tech Accessible Tests
ITAP
Webinars
Atlanta Center for Microsystems Engineered Point-of-Care Technologies
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases
Center for Innovation in Point of Care Technologies for HIV/AIDS at Northwestern
Center for Advancing Point of Care in Heart, Lung, Blood, and Sleep Diseases
Center news
Funding Opportunity: Blueprint MedTech Spring Award Competition
CIMIT’s CINTA and NeuroTech Harbor, through the NIH Blueprint MedTech program, have started accepting pre-proposals from academic and industry applicants who have emerging technologies that aim to improve the prevention, diagnosis, and/or treatment of disorders involving the nervous system or consequences of such a disease or injury.
Awards up to $500K will be made available to the most promising and innovative neurotechnologies to help accelerate their development toward commercialization.
A major emphasis of this program is to create opportunities for diverse innovators, including those who have been traditionally underrepresented in the neurotech space.
Program Details:
- Awards up to $500K to help support development toward commercialization
- Mentorship from experienced medtech commercialization experts
- Support to address business, regulatory, clinical, and technical project areas
Pre-proposals are due no later than: March 16th
In the News
NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests
The need for new test verification and regulatory support for innovative diagnostics
NIH-funded screening study builds case for frequent COVID-19 antigen testing
RADx partnerships speed new COVID testing
Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort
RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)
COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative
The National Strategy From the COVID-19 Response and Pandemic Preparedness
Our partners
National Heart, Lung, and Blood Institute
National Institute of Allergy and Infectious Diseases
National Center for Complementary and Integrative Health
Fogarty International Center
Office of Behavioral and Social Sciences Research
Office of AIDS Research
Office of Disease Prevention